Boston Medical Center, a private, not-for-profit, equity-led academic medical center, is the winner of AHA’s 2024 Foster G. McGaw Prize for its leadership and initiatives to improve care quality, care access and health equity in its surrounding community. BMC will be awarded $100,000 and will receive the prize at the AHA Leadership Summit July 22 in San Diego. 

“Boston Medical Center is a national leader in going outside the four walls of the hospital and into the community to advance health care access and outcomes, especially for the most underserved,” said AHA President and CEO Rick Pollack. “By working diligently with a wide range of community partners — including nontraditional ones — Boston Medical Center serves as a model to the hospital field in efforts to reduce health and social inequities.” 

Englewood Health in Englewood, N.J. and NewYork-Presbyterian in New York City were also recognized as finalists and will receive $10,000 each. Read more about the prize recipients and their initiatives here. The Foster G. McGaw Prize is sponsored by the Baxter International Foundation, the AHA and AHA’s non-profit affiliate Health Research & Educational Trust. 

Related News Articles

Headline
The AHA and Press Ganey are working to understand the challenges hospitals and health systems face when engaging their workforce and create resources leaders…
Blog
Public
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
Applications for the 2026 AHA Dick Davidson NOVA Award are due Oct. 14. The award recognizes hospitals that demonstrate outstanding collaboration with…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…